155
Views
6
CrossRef citations to date
0
Altmetric
Mutation Reports

A novel SVA retrotransposon insertion in the CHM gene results in loss of REP-1 causing choroideremia

ORCID Icon, , & ORCID Icon
Pages 341-344 | Received 10 Apr 2020, Accepted 09 May 2020, Published online: 22 May 2020

References

  • Mitsios A, Dubis AM, Moosajee M. Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments. Ther Adv Ophthalmolo. 2018;10:251584141881749.2018. 10:2515841418817490.
  • Jolly JK, Xue K, Edwards TL, Groppe M, MacLaren RE.Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging. Invest Ophthalmol Vis Sci. 2017;58(12):5575.
  • Bokhoven HV, José AJM, Van Den Hurk BL, Philippe C, Gilgenkrantz S, Jong PD. Cloning and characterization of the human choroideremia gene. Hum Mol Genet 1994;3:1041–46.
  • Chi JY, MacDonald IM, Hume S.Copy number variant analysis in CHM to detect duplications underlying choroideremia. Ophthalmic Genet. 2012;34(4):229–33.
  • Edwards T, Williams J, Patrício M, Simunovic M, Shanks M, Clouston P. Novel non-contiguous exon duplication in choroideremia. Clin Genet 2017;93:144–48.
  • Radziwon A, Arno G, Wheaton DK, Mcdonagh EM, Baple EL, Webb-Jones K. Single-base substitutions in the CHM promoter as a cause of choroideremia. Hum Mutat 2017;38:704–15.
  • José AJM, Van Den Hurk DJ, Van De Pol R, Wissinger B, Driel MAV, Hoefsloot LH, Wijs IJD. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon. Hum Genet 2003;113:268–75.
  • Palma MMD, Motta FL, Gomes CP, Salles MV, Pesquero JB, Sallum JMF.Synonymous variant in the CHM gene causes aberrant splicing in choroideremia. Invest Ophthalmol Vis Sci. 2020;61(2):38.
  • Ono M, Kawakami M, Takezawa T.A novel human nonviral retroposon derived from an endogenous retrovirus. Nucleic Acids Res. 1987;15(21):8725–37.
  • Ostertag EM, Goodier JL, Zhang Y, Kazazian HH.SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet. 2003;73(6):1444–51.
  • Shen L, Wu LC, Sanlioglu S, Chen R, Mendoza AR, Dangel AW, Carroll MC, Zipf WB, Yu CY. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. J Biol Chem. 1994;269:8466–76.
  • Srikanta D, Sen SK, Huang CT, Conlin EM, Rhodes RM, Batzer MA.An alternative pathway for Alu retrotransposition suggests a role in DNA double-strand break repair. Genomics. 2009;93(3):205–12.
  • Damert A, Raiz J, Horn AV, Lower J, Wang H, Xing J. 5-Transducing SVA retrotransposon groups spread efficiently throughout the human genome. Genome Res. 2009 Mar;19(11):1992–2008.
  • Hancks DC, Ewing AD, Chen JE, Tokunaga K, Kazazian HH.Exon-trapping mediated by the human retrotransposon SVA. Genome Res. 2009;19(11):1983–91.
  • Hancks DC, Goodier JL, Mandal PK, Cheung LE, Kazazian HH. Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum Mol Genet. 2011 Feb;20(17):3386–400.
  • Tavares E, Tang CY, Vig A, Li S, Billingsley G, Sung W. Retrotransposon insertion as a novel mutational event in Bardet-Biedl syndrome. Mol Genet Genomic Med. 2018;7:2.
  • Furgoch MJ, Mewes-Arès J, Radziwon A, MacDonald IM. Molecular genetic diagnostic techniques in choroideremia. Mol Vis, 2014 Apr 25;20: 535–44. PMID: 24791138.
  • Hancks DC, Kazazian HH. Roles for retrotransposon insertions in human disease. Mobile DNA. 2016;7(1).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.